Dimethyl fumarate Neuraxpharm Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Mylan Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Polpharma Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Tecfidera Evrópusambandið - íslenska - EMA (European Medicines Agency)

tecfidera

biogen netherlands b.v. - dímetýl fúmarat - margvísleg sclerosis - Ónæmisbælandi lyf - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Elvanse Adult Hart hylki 30 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 30 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 30 mg

Elvanse Adult Hart hylki 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 50 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 50 mg

Elvanse Adult Hart hylki 70 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 70 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 70 mg

Volidax Hart hylki 30 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

volidax hart hylki 30 mg

teva b.v.* - lisdexamfetaminum dimesylate - hart hylki - 30 mg